Literature DB >> 19630791

Slow thrombin is zymogen-like.

J A Huntington1.   

Abstract

Blood coagulation is the result of a cascade of zymogen activation events; however, its initiation is allosteric. Factor VIIa circulates in a zymogen-like state and is allosterically activated by binding to tissue factor. Thrombin, the final protease generated in the blood coagulation cascade, has also been shown to exist in a low activity state in the absence of cofactors, and the structural features of this 'slow' form have been studied for many years. In this manuscript, I will review the general features that render zymogens inactive and how proteolytic cleavage results in activation, but I will also show how this distinction is blurred by zymogens that have activity (protease-like zymogens) and proteases with low activity (zymogen-like proteases). This will then be applied in the analysis of slow thrombin to reveal how allosteric activation of thrombin simply reflects the conversion from a zymogen-like enzyme to an active serine protease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630791      PMCID: PMC2717038          DOI: 10.1111/j.1538-7836.2009.03365.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  30 in total

1.  Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation.

Authors:  Rainer Friedrich; Peter Panizzi; Pablo Fuentes-Prior; Klaus Richter; Ingrid Verhamme; Patricia J Anderson; Shun-Ichiro Kawabata; Robert Huber; Wolfram Bode; Paul E Bock
Journal:  Nature       Date:  2003-10-02       Impact factor: 49.962

2.  Allosteric regulation of the cofactor-dependent serine protease coagulation factor VIIa.

Authors:  W Ruf; C D Dickinson
Journal:  Trends Cardiovasc Med       Date:  1998-11       Impact factor: 6.677

3.  The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro-Trp segment and active site residues upon ligand binding.

Authors:  M G Malkowski; P D Martin; J C Guzik; B F Edwards
Journal:  Protein Sci       Date:  1997-07       Impact factor: 6.725

4.  Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.

Authors:  M Renatus; R A Engh; M T Stubbs; R Huber; S Fischer; U Kohnert; W Bode
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

5.  Molecular recognition by thrombin. Role of the slow-->fast transition, site-specific ion binding energetics and thermodynamic mapping of structural components.

Authors:  Y Ayala; E Di Cera
Journal:  J Mol Biol       Date:  1994-01-14       Impact factor: 5.469

6.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

7.  Inactivation of bovine trypsinogen and chymotrypsinogen by diisopropylphosphorofluoridate.

Authors:  P H Morgan; N C Robinson; K A Walsh; H Neurath
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

Review 8.  Cofactor-induced and mutational activity enhancement of coagulation factor VIIa.

Authors:  O H Olsen; E Persson
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

9.  Thrombin is a Na(+)-activated enzyme.

Authors:  C M Wells; E Di Cera
Journal:  Biochemistry       Date:  1992-12-01       Impact factor: 3.162

10.  Crystal structure of wild-type human thrombin in the Na+-free state.

Authors:  Daniel J D Johnson; Ty E Adams; Wei Li; James A Huntington
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

View more
  15 in total

1.  Kinetic dissection of the pre-existing conformational equilibrium in the trypsin fold.

Authors:  Austin D Vogt; Pradipta Chakraborty; Enrico Di Cera
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

2.  Meizothrombin is an unexpectedly zymogen-like variant of thrombin.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

Review 3.  Essential role of conformational selection in ligand binding.

Authors:  Austin D Vogt; Nicola Pozzi; Zhiwei Chen; Enrico Di Cera
Journal:  Biophys Chem       Date:  2013-09-25       Impact factor: 2.352

4.  Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling.

Authors:  Kyle E Landgraf; Lydia Santell; Karen L Billeci; Clifford Quan; Judy C Young; Henry R Maun; Daniel Kirchhofer; Robert A Lazarus
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

5.  Evidence of the E*-E equilibrium from rapid kinetics of Na+ binding to activated protein C and factor Xa.

Authors:  Austin D Vogt; Alaji Bah; Enrico Di Cera
Journal:  J Phys Chem B       Date:  2010-09-02       Impact factor: 2.991

6.  NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation.

Authors:  Bernhard C Lechtenberg; Daniel J D Johnson; Stefan M V Freund; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-21       Impact factor: 11.205

7.  Ligand binding shuttles thrombin along a continuum of zymogen- and proteinase-like states.

Authors:  Parvathi Kamath; James A Huntington; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2010-07-16       Impact factor: 5.157

8.  Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.

Authors:  Daniel J D Johnson; Jonathan Langdown; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  Molecular basis of thrombomodulin activation of slow thrombin.

Authors:  T E Adams; W Li; J A Huntington
Journal:  J Thromb Haemost       Date:  2009-07-28       Impact factor: 5.824

10.  Proton bridging in the interactions of thrombin with hirudin and its mimics.

Authors:  Ildiko M Kovach; Lazaros Kakalis; Frank Jordan; Daoning Zhang
Journal:  Biochemistry       Date:  2013-04-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.